Evidence map›Paper›PMID 33099744›Full record

ArticleMolecular neurobiology2021

Epigenetic Blockade of Hippocampal SOD2 Via DNMT3b-Mediated DNA Methylation: Implications in Mild Traumatic Brain Injury-Induced Persistent Oxidative Damage.

Nagalakshmi Balasubramanian, Sneha Sagarkar, Amit G Choudhary, Dadasaheb M Kokare, Amul J Sakharkar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Dorsal raphe tau pathology disrupts sleep-wake orchestration and sleep architecture in a sex-specific manner.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. The Role of Methylation Modification in Neural Injury and Repair.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nagalakshmi BalasubramanianDepartment of Biotechnology, Savitribai Phule Pune University, Pune, 411 007, India.
Sneha SagarkarDepartment of Biotechnology, Savitribai Phule Pune University, Pune, 411 007, India.
Amit G ChoudharyDepartment of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, 440 033, India.
Dadasaheb M KokareDepartment of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, 440 033, India.
Amul J SakharkarDepartment of Biotechnology, Savitribai Phule Pune University, Pune, 411 007, India. amul.sakharkar@unipune.ac.in.ORCID http://orcid.org/0000-0002-7382-0945
Savitribai Phule Pune University · INRashtrasant Tukadoji Maharaj Nagpur University · IN

Funding

Council for Scientific and Industrial Research (IN) 37[1718]/18/EMR-IIDepartment of Science and Technology (DST-INSPIRE) (IN)) DST/INSPIRE/04/2018/000529Science and Engineering Research Board EMR/2017/000621University Grants Commission F.4-5/151-FRP/2014/BSRUniversity Research Project Scheme Dev./RTMNURP/AH/2115
6 · The paper itself

Abstract

The recurrent events of mild trauma exacerbate the vulnerability for post-traumatic stress disorder; however, the underlying molecular mechanisms are scarcely known. The repeated mild traumatic brain injury (rMTBI) perturbs redox homeostasis which is primarily managed by superoxide dismutase 2 (SOD2). The current study investigates the role of DNA methylation in SOD2 gene regulation and its involvement in rMTBI-induced persistent neuropathology inflicted by weight drop injury paradigm. The oxidative damage, neurodegenerative indicators, and SOD2 function and its regulation in the hippocampus were analyzed after 48 h and 30 days of rMTBI. The temporal and episodic increase in ROS levels (oxidative stress) heightened 8-hydroxyguanosine levels indicating oxidative damage after rMTBI that was concomitant with decline in SOD2 function. In parallel, occupancy of DNMT3b at SOD2 promoter was higher post 30 days of the first episode of rMTBI causing hypermethylation at SOD2 promoter. This epigenetic silencing of SOD2 promoter was sustained after the second episode of rMTBI causing permanent blockade in SOD2 response. The resultant oxidative stress further culminated into the increasing number of degenerating neurons. The treatment with 5-azacytidine, a pan DNMT inhibitor, normalized DNA methylation levels and revived SOD2 function after the second episode of rMTBI. The release of blockade in SOD2 expression by DNMT inhibition also normalized the post-traumatic oxidative consequences and relieved the neurodegeneration and deficits in learning and memory as measured by novel object recognition test. In conclusion, DNMT3b-mediated DNA methylation plays a critical role in SOD2 gene regulation in the hippocampus, and the perturbations therein post rMTBI are detrimental to redox homeostasis manifesting into neurological consequences.

Indexed as

Epigenesis, GeneticAnimalsAzacitidineBrain Injuries, TraumaticDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Methyltransferase 3BDown-RegulationGene SilencingHippocampusMaleModels, BiologicalNerve DegenerationOxidative StressPC12 CellsPromoter Regions, GeneticAzacitidineDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BSuperoxide DismutaseSuperoxide Dismutase 2DNA methylationHippocampusMild traumatic brain injuryNeurodegenerationSuperoxide dismutase 2

Identifiers

PMID33099744
OpenAlexW3093968283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.